Grace Therapeutics (GRCE) Return on Sales [ROS] (2012 - 2026)
Grace Therapeutics (GRCE) recorded Return on Sales [ROS] of -11288.65% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9773.95 percentage points from -1514.71% a year earlier and down 9107.49 percentage points from the prior quarter.
Grace Therapeutics (GRCE) Return on Sales [ROS] (2012 - 2026) Analysis & Trends
On a TTM basis, Grace Therapeutics' Return on Sales [ROS] came in at -3837.08% as of Jun 30, 2026, down 1712.54 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -1617.08%, up 673.99 percentage points from FY2025.
- Annual Return on Sales [ROS] has a five-year change of +6759.96 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, Return on Sales [ROS] came in at -2291.07% in FY2025 (-822.27 pp) and -1468.80% in FY2024.
- The fiscal Q1 2027 figure is the lowest quarterly Return on Sales [ROS] since fiscal Q3 2016.
- On a year-over-year basis, Return on Sales [ROS] rose in three of the last five quarters, with an average year-over-year change of -1390.25 percentage points.
- Per Business Quant, the preceding three fiscal quarters came in at -2181.16% (Q4 2026), -1423.84% (Q3 2026) and -1470.35% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 32.98% |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | -1,488.31% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11,288.65% |
| Mar 31, 2026 | -2,181.16% |
| Dec 31, 2025 | -1,423.84% |
| Sep 30, 2025 | -1,470.35% |
| Jun 30, 2025 | -1,514.71% |
| Mar 31, 2025 | -1,729.89% |
| Dec 31, 2024 | -2,916.54% |
| Sep 30, 2024 | -2,654.40% |
| Jun 30, 2024 | -2,111.91% |
| Mar 31, 2022 | -7,953.57% |
| Dec 31, 2021 | -987.12% |
| Mar 31, 2021 | -2,000.00% |
| Dec 31, 2020 | -2,424.69% |
| Mar 31, 2018 | -0.43% |
| Dec 31, 2017 | -4,377.04% |
| Sep 30, 2017 | -846.22% |
| Nov 30, 2016 | -199.71% |
| Aug 31, 2016 | -44,508.35% |
| May 31, 2016 | -79,155.12% |
| Nov 30, 2015 | -39,180.13% |
Grace Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();